title: Obesity and the sympathetic nervous system.
abstract: Several epidemiological studies have shown that obesity represents an independent risk factor for development of cardiovascular diseases, including hypertension, myocardial ischaemia, and cardiac arrhythmias. Although the metabolic and the haemodynamic alterations occurring in the obese state have been well defined for several years, our knowledge on the sympathetic alterations occurring in this condition is more scarce and controversial. This paper reviews the evidence that human obesity is characterized by abnormalities in sympathetic cardiovascular control, in the light of the results of recent studies performed by employing a sensitive technique to assess sympathetic activity in humans, i.e. microneurography. Evidence is provided that sympathetic overactivity is a common hallmark of the obese state, even when blood pressure levels are within the normal range. It will also discuss the potential mechanisms responsible for this sympathetic activation, suggesting that overweight-related metabolic alterations, such as the insulin resistance state, and abnormalities in sympathetic cardiovascular control exerted by arterial baroreceptors may play a pathogenetic role. Finally, the effects of body weight reduction on the sympathetic overactivity which characterizes the obese state will also be examined.
authors.affiliation: Cattedra di Medicina Interna 1, University of Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Grassi
authors.forename: B M
authors.initials: BM
authors.lastname: Cattaneo
authors.forename: G
authors.initials: G
authors.lastname: Seravalle
authors.forename: M
authors.initials: M
authors.lastname: Colombo
authors.forename: F
authors.initials: F
authors.lastname: Cavagnini
authors.forename: G
authors.initials: G
authors.lastname: Mancia
mesh_terms: D002149:Energy Intake; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D009132:Muscles / Q000294:innervation; D009765:Obesity / Q000178:diet therapy / Q000503:physiopathology*; D012307:Risk Factors; D013564:Sympathetic Nervous System / Q000502:physiology*; D015431:Weight Loss / Q000502:physiology